Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hooker

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
British Journal of Clinical Pharmacology|February 20, 2014
Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studiesJoakim Nyberg, Caroline Bazzoli, Kay Ogungbenro, et al.
The AAPS Journal|June 22, 2011
Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysisRoberto Bizzotto, Stefano Zamuner, Enrica Mezzalana, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 23, 2024
Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic end pointsXiaomei Chen, Henrik B Nyberg, Mark Donnelly, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 29, 2024
Evaluation of model-integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methodsHenrik Bjugård Nyberg, Xiaomei Chen, Mark Donnelly, et al.
Neuroimage|March 20, 2012
Non-linear mixed effects modelling of positron emission tomography data for simultaneous estimation of radioligand kinetics and occupancy in healthy volunteersMatts Kågedal, Zsolt Cselényi, Svante Nyberg, et al.
The Journal of Nutrition|August 16, 2013
Chain length of dietary alkylresorcinols affects their in vivo elimination kinetics in ratsMatti Marklund, Eric A Strömberg, Andrew C Hooker, et al.
Journal of Clinical Pharmacology|November 10, 2011
Plasma and cerebrospinal fluid pharmacokinetics of naproxen in childrenPyry Välitalo, Elina Kumpulainen, Minna Manner, et al.
Clinical Pharmacology and Therapeutics|March 26, 2010
Adaptive-optimal design in PET occupancy studiesS Zamuner, V L Di Iorio, J Nyberg, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 7, 2026
Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental DesignFenja Klima, Anna M Mc Laughlin, Robin Michelet, et al.
The Journal of Nutrition|October 22, 2014
Simultaneous pharmacokinetic modeling of alkylresorcinols and their main metabolites indicates dual absorption mechanisms and enterohepatic elimination in humansMatti Marklund, Eric A Strömberg, Helle N Lærke, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
British Journal of Clinical Pharmacology|February 20, 2014
Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studiesJoakim Nyberg, Caroline Bazzoli, Kay Ogungbenro, et al.
The AAPS Journal|June 22, 2011
Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysisRoberto Bizzotto, Stefano Zamuner, Enrica Mezzalana, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 23, 2024
Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic end pointsXiaomei Chen, Henrik B Nyberg, Mark Donnelly, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 29, 2024
Evaluation of model-integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methodsHenrik Bjugård Nyberg, Xiaomei Chen, Mark Donnelly, et al.
Neuroimage|March 20, 2012
Non-linear mixed effects modelling of positron emission tomography data for simultaneous estimation of radioligand kinetics and occupancy in healthy volunteersMatts Kågedal, Zsolt Cselényi, Svante Nyberg, et al.
The Journal of Nutrition|August 16, 2013
Chain length of dietary alkylresorcinols affects their in vivo elimination kinetics in ratsMatti Marklund, Eric A Strömberg, Andrew C Hooker, et al.
Journal of Clinical Pharmacology|November 10, 2011
Plasma and cerebrospinal fluid pharmacokinetics of naproxen in childrenPyry Välitalo, Elina Kumpulainen, Minna Manner, et al.
Clinical Pharmacology and Therapeutics|March 26, 2010
Adaptive-optimal design in PET occupancy studiesS Zamuner, V L Di Iorio, J Nyberg, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 7, 2026
Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental DesignFenja Klima, Anna M Mc Laughlin, Robin Michelet, et al.
The Journal of Nutrition|October 22, 2014
Simultaneous pharmacokinetic modeling of alkylresorcinols and their main metabolites indicates dual absorption mechanisms and enterohepatic elimination in humansMatti Marklund, Eric A Strömberg, Helle N Lærke, et al.
Pageof 16